title: [Pseudomembranous colitis probably caused by Clostridium difficile: first case appeared during preventive treatment of infection of ascitic fluid with norfloxacin].
authors.forename: R
authors.initials: R
authors.lastname: Tordjman
authors.forename: K
authors.initials: K
authors.lastname: Benfiguig
authors.forename: C
authors.initials: C
authors.lastname: Eugène
authors.forename: E
authors.initials: E
authors.lastname: Mitry
authors.forename: J
authors.initials: J
authors.lastname: Merrer
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001202:Ascitic Fluid / Q000517:prevention & control*; D016360:Clostridioides difficile / Q000302:isolation & purification*; D003015:Clostridium Infections / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009643:Norfloxacin / Q000009:adverse effects* / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D014640:Vancomycin; D009643:Norfloxacin
vernacular_title: Colite pseudo-membraneuse probablement due à Clostridium difficile: premier cas apparu lors d'un traitement préventif de l'infection du liquide d'ascite par la norfloxacine.